Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.

BMC cardiovascular disorders·2020
Same author

Activation of adenosine A2b receptor attenuates high glucose-induced apoptosis in H9C2 cells via PI3K/Akt signaling.

In vitro cellular & developmental biology. Animal·2018
Same author

Klotho attenuates isoproterenol-induced hypertrophic response in H9C2 cells by activating Na<sup>+</sup>/K<sup>+</sup>-ATPase and inhibiting the reverse mode of Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger.

In vitro cellular & developmental biology. Animal·2018
Same author

The CD4/CD8 ratio is associated with coronary artery disease (CAD) in elderly Chinese patients.

International immunopharmacology·2016
Same author

FGF21 represses cerebrovascular aging via improving mitochondrial biogenesis and inhibiting p53 signaling pathway in an AMPK-dependent manner.

Experimental cell research·2016
Same author

Triglycerides are Independently Associated with Atherosclerosis in Elderly Chinese Patients.

Clinical laboratory·2016

Related Experiment Video

Updated: Jun 1, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Bacteriological differences between COPD exacerbation and community-acquired pneumonia.

Xue-Jun Li1, Qi Li, Liang-Yi Si

  • 1Department of Geriatrics, Southwest Hospital, Third Military Medical University, Chongqing, China. lixuejun3@126.com

Respiratory Care
|May 25, 2011
PubMed
Summary

Pseudomonas aeruginosa is the leading cause of COPD exacerbation infections, while Streptococcus pneumoniae is most common in community-acquired pneumonia. This finding aids antibiotic treatment guidance for respiratory infections.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: Jun 1, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) exacerbations and community-acquired pneumonia (CAP) share overlapping symptoms but differ in causative pathogens.
  • Understanding pathogen distribution is crucial for effective antibiotic stewardship in respiratory infections.

Purpose of the Study:

  • To compare pathogen prevalence and antibiotic susceptibility in COPD exacerbation versus CAP.
  • To inform antibiotic treatment strategies for these distinct respiratory conditions.

Main Methods:

  • Retrospective analysis of 586 COPD exacerbation and 345 CAP patient records (Jan 2007-Dec 2008).
  • Included sputum culture results, pathogen identification, antibiotic susceptibility, and clinical data.

Main Results:

  • Positive sputum cultures were found in 47% of COPD exacerbation and 53% of CAP patients.
  • COPD exacerbation pathogens: Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Acinetobacter baumannii, Haemophilus influenzae.
  • CAP pathogens: Streptococcus pneumoniae, H. influenzae, K. pneumoniae, S. aureus, E. coli.

Conclusions:

  • Pseudomonas aeruginosa was the predominant pathogen in COPD exacerbation.
  • Streptococcus pneumoniae was the most common pathogen in CAP.
  • P. aeruginosa prevalence was higher in severe COPD exacerbations, guiding targeted therapy.